cilastatin has been researched along with Klebsiella Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W | 1 |
| Amadesi, S; Ambretti, S; Bartoletti, M; Bovo, F; Bussini, L; Gaibani, P; Lazzarotto, T; Viale, P | 1 |
| Agudelo, M; Pelaez, CA; Rodriguez, CA; Vesga, O | 1 |
| Ciszek, M; Dobrzaniecka, K; Grochowiecki, T; Grygiel, K; Młynarczyk, G; Pączek, L; Sańko-Resmer, J; Wilkowski, P; Łabuś, A | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
| Donskey, CJ; Pultz, MJ | 1 |
| Etoh, T; Hirose, M; Ishibashi, H; Muro, H; Ohta, S; Shirasu, T; Suzuki, K; Tanio, N | 1 |
| Ehrhardt, AF; Sanders, CC; Thomson, KS; Trujillano-Martin, I; Watanakunakorn, C | 1 |
| Confino-Cohen, R; Goldberg, A; Lang, R | 1 |
| Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW | 1 |
| Amano, H; Kawazu, H; Nishiwaki, K; Saito, H; Saka, H; Sakai, S; Senda, Y; Shimokata, K; Torii, Y; Yamamoto, M | 1 |
| Casali, W; Cogo, R; Falchi, M; Fraschini, F; Gattei, G; Scaglione, F | 1 |
13 other study(ies) available for cilastatin and Klebsiella Infections
| Article | Year |
|---|---|
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines | 2021 |
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cilastatin; Drug Combinations; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.
Topics: Animals; Anti-Bacterial Agents; Biotransformation; Brain; Cilastatin; Dipeptidases; Drug Stability; Drugs, Generic; GPI-Linked Proteins; Guinea Pigs; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Microbial Sensitivity Tests; Muscle, Skeletal; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Therapeutic Equivalency; Thienamycins; Thigh; Treatment Outcome | 2014 |
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Drug Combinations; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Genotype; Gentamicins; Humans; Imipenem; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
[Postoperative penicillin-resistant streptococcus pneumonia in lung cancer patient].
Topics: Aged; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Lung Neoplasms; Male; Penicillin Resistance; Pneumonia, Pneumococcal; Postoperative Complications; Sepsis; Streptococcus pneumoniae; Ventilators, Mechanical | 2008 |
Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
Topics: Aged; Cefoxitin; Cilastatin; Diagnosis, Differential; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male | 1993 |
Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Desensitization, Immunologic; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Klebsiella Infections; Middle Aged | 1997 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins | 1998 |
[Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Imipenem; Klebsiella Infections; Male; Middle Aged; Pseudomonas; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus | 1990 |
Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.
Topics: Aged; Bronchial Diseases; Ceftriaxone; Cilastatin; Drug Administration Schedule; Drug Combinations; Haemophilus Infections; Haemophilus influenzae; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Sputum; Streptococcal Infections; Streptococcus pneumoniae | 1988 |